NRXP has entered a transformative partnership with Alvogen Pharmaceuticals for the development and marketing of NRX-101. Beyond its mental health applications, NRX-101 shows promise as a non-opioid ...

A multi-ancestry genome-wide study of 158,036 people with bipolar disorder and 2,796,499 control individuals identified 298 genomic regions associated with the disease. Variations in 36 genes were ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, and often effective interventions. Stephen Ferber, MD, is a board-certified ...

As a psychiatrist, I have two options for treating my patients: mood stabilizers, which are usually anticonvulsants, and antipsychotics. Antipsychotics are a key treatment in managing bipolar I ...